- SAVE THE DATE
Thursday 12 October, London
- SAVE THE DATE
Thursday 12 October. London
2016 BIA Supporters
Risk management solutions for life sciences companies are both complex and specialised. When you team up with the Gallagher Life Sciences Practice, you will work with an insurance broker with thorough knowledge of your industry and the regulatory environment. We will leverage the marketplace on your behalf to help protect your company’s bottom line from the financial devastation that could result from a loss or lawsuit. Our team of experts will work with you to customise risk management and insurance solution programs that meet your unique needs and protect your organisation under the best possible terms and conditions.
Our Gallagher life sciences team has experience in nearly every phase of the life science process - from discovery to development to production. This includes insuring human clinical trials in most countries around the world. Whether you’re a start-up or a multinational, whether you’re operating in the UK or overseas, we help to prepare a range of high performance, bespoke insurance solutions that may include:
- Clinical Trials Liability
- Products Liability and Product Recall
- Property coverage at your premises, at third party locations or in Transit
- Business Interruption cover for loss of income or unproductive cash burn
- Directors’ and Officers’ Liability
- Intellectual Property Infringement Defence and/or Pursuit
- Errors and Omissions and Professional L:iability
- Medical Malpractice
- Cyber Risks
Helping shape a new age of healthcare
There is no other life sciences company quite like GE Healthcare’s Life Sciences business. Part of GE Healthcare, we are a $4 billion business of 11,500 people in over 100 countries, at work enabling a new era in medicine. We have the agility and unmatched global capabilities that come with being part of a company that continually pushes the frontiers of science and technology.
For more than 60 years, GE Healthcare Life Sciences has supported the development and use of new therapies, helping accelerate the journey from biological understanding to clinical therapy. At GE Healthcare Life Sciences, we believe that the practice of science and medicine is at a turning point; we are on the cusp of understanding biological and genetic mysteries and uncovering treatments for complex diseases that would have been unthinkable just a few years ago. We are supporting the development of more personalized and targeted therapies by advancing cell therapy. We are helping healthcare practitioners gain new understanding of the body and enabling earlier and more precise diagnosis of disease with our imaging technologies. And as the development of molecules and medicines becomes more complex, we are reimagining the processes and manufacturing operations that make large scale biopharmaceutical production possible.
Headquartered in the United Kingdom, we provide expertise and tools in biotechnology, life sciences and clinical diagnostics, supporting fields from basic cell, protein and drug discovery research, to large-scale biopharmaceutical manufacturing, and diagnostic imaging in diseases such as cancer, heart disease and neurological disorders.
Horizon Discovery is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines. Horizon has a diverse and international customer base of over 1,200 organizations across more than 50 countries, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers. The Group supplies its products and services into multiple markets, estimated to total in excess of £29 billion by 2015.
Horizon’s core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell-lines. Horizon offers over 20,000 catalogue products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These ‘patients-in-a-test-tube’ are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness, and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments.
In addition, Horizon provides custom cell line and in vivo model generation services for research and bioproduction applications, quantitative molecular reference standards, in vivo disease models, and contract research and custom screening services.
Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing new medicines including monoclonal antibodies, recombinant proteins, regenerative medicines, vaccines and gene therapy vectors as well as classic pharmaceuticals.
Pall’s leading edge bioreactors, filters, single-use systems, chromatography media and analytical technologies, as well as technical services in validation, assays and process optimization applicable to laboratory and pilot-scale development, play an essential role in the industry’s ability to manufacture these products. As an established provider of analytical and purification technologies, Pall supports faster development of new medicines around the world
Headquartered in Radnor, Pennsylvania, VWR is a leading, global, independent provider of products, services and solutions to laboratory and production facilities. With sales in excess of $4.3 billion in 2014, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customised solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 8,500 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
Registered in the UK in 1985, VWR UK now employs over 550 associates. Situated near Lutterworth, Leicestershire is our Customer Service Centre and state of the art, purpose built warehouse. We store on hand product stocks of around 40,000 stocked lines located in 17,000 m2 of leading edge storage facilities holding approx. £15 million worth of stock at any one time. We pride ourselves as being one of the largest distribution centres of its kind in Europe!